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Objective: To evaluate the efficacy of a weekly interdisciplinary program (WIP) consisted 
of educational activities, physical therapy, stretching, ergonomics, posture guidance com-
bined with cognitive behavioral strategies and approaches to psychosocial and occupa-
tional factors in order to determine whether this intervention would be effective to short 
and medium-term improvement of symptoms in these patients. 
Methods: This was a single-center study, randomized single blind controlled trial with a 
sample test group (T), with a diagnosis of FMS (n = 12), and a control group (C) subjected to 
Pain Clinic referral (n = 15). The instruments used at two different times were the Fibromy-
algia Impact Questionnaire (FIQ), Visual Analogue Scale (VAS) and Post-Sleep Protocol (PSI). 
To assess quality of life, we used the SF-12. 
Results: In samples, both groups were predominantly female, mean age of 42.5 ± 9.8 years, 
43% married, average schooling of 8.3 ± 4.5 years. It was reported a mean of 4.2 years pain 
and an average of two years for the diagnosis of SFM from the group T. There was statisti-
cal difference between the groups in terms of efficacy post intervention WIP, in almost all 
outcome measures. 
Conclusion: It was found that weekly interdisciplinary program (WIP) has contributed to 
improving the quality of life of patients with fibromyalgia.
© 2014 Sociedade Brasileira de Reumatologia. Published by Elsevier Editora Ltda. 
All rights reserved.
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Estudo randomizado e controlado de uma intervenção terapêutica grupal 
em pacientes com síndrome fibromiálgica
Palavras-chave:
Fibromialgia
Estudo controlado
Intervenção grupal
r e s u m o
Objetivo: Avaliar a eficácia de um programa interdisciplinar semanal (PIS) composto de ati-
vidades educativas, terapias físicas, alongamento, ergonomia, orientações posturais com-
binado com estratégias cognitivas e comportamentais e abordagens de aspectos psicosso-
ciais e ocupacionais, a fim de determinar se esta intervenção seria efetiva em curto e médio 
prazos para melhora dos sintomas destes pacientes. 
Casuística e métodos: Trata-se de um estudo unicêntrico, randomizado, simples cego e con-
trolado com amostra de um grupo-teste (T), com diagnóstico de SFM (n = 12), e de um 
grupo-controle (C) submetido a interconsulta na Clínica da Dor (n = 15). Os instrumentos 
utilizados em dois momentos distintos foram: Questionário de Impacto de Fibromialgia 
(FIQ), Escala Visual Analógica (EVA) e Protocolo Pós-Sono (PSI). Para avaliar a qualidade de 
vida, foi utilizado o Questionário SF-12. 
Resultados: Na amostra dos dois grupos houve predomínio do gênero feminino, média de 
idade de 42,5±9,8 anos, 43% casados e média de escolaridade de 8,3±4,5 anos. Foi relatado 
um tempo médio de dor de 4,2 anos e uma média de dois anos para o diagnóstico de SFM 
no grupo T. Houve diferença estatística entre os grupos, em relação à eficácia pós-interven-
ção do PIS, em quase todos os desfechos analisados. 
Conclusão: Verificou-se que o programa interdisciplinar semanal (PIS) contribuiu para me-
lhora da qualidade de vida dos pacientes fibromiálgicos.
© 2014 Sociedade Brasileira de Reumatologia. Publicado por Elsevier Editora Ltda. 
Todos os direitos reservados.
Introduction
The fibromyalgia syndrome (FMS) is a rheumatic syndrome 
of unknown etiology that predominantly affects women. It is 
characterized by diffuse and chronic musculoskeletal pain, in 
addition to specific anatomical sites with pain elicited by pal-
pation, called tender points. Other symptoms such as fatigue, 
sleep disturbances, morning stiffness and psychological dis-
orders such as anxiety and depression are often associated.1-3
Statistic data shows that FMS affects 3-5% of general popu-
lation, occurring in all ages with chronic symptoms that can 
fluctuate throughout the day and with inactivity, compromis-
ing about a quarter of those affected.3
The clinical picture of FMS is complex, and several works4,5 
propose multidisciplinary teams to perform interventions, 
highlighting programs with exercise sessions,4 relaxation,5 
stress management and compartmental cognitive therapy6 
that consist in extending the adherence to treatment and mo-
tivating patients to remain active.7
The mean duration of interdisciplinary programs varies 
from one to six months, usually performed with groups of 10 
and 25 individuals. The justification for choosing this type of 
intervention proves itself by improving the quality of life and 
health status of patients with FMS.8,9
Regarding the pathogenesis of FMS, it is not well defined 
yet, although psychosomatic phenomena occur in most 
patients.10 In addition to this possible effect, some areas of 
the nervous system functioning may represent a role in the 
pathogenesis of FMS, which include: changes in pain sen-
sitivity,11,12 and also on autonomic and neuroendocrine sys-
tems.13-15 Bacterial and viral agents may also be related to the 
origin of this syndrome,16 and there is some association be-
tween the disease and infection by hepatitis virus C.11
Considering that SFM probably has multifactorial etiology 
that still remains unclear, recent trials17,18 reported that the 
reorientation of attention for the treatment of the patients 
to this combination of factors and the education of these pa-
tients (so that they can control their symptoms) are measures 
that could promote changes in behavior and improve their 
functional capacity. 
Given this context, the objective of this trial was to evalu-
ate the efficacy of a weekly interdisciplinary program (WIP) 
consisting of educational activities, physical therapy, stretch-
ing, ergonomics and postural orientations combined with 
cognitive-behavioral strategies and approaches to psychoso-
cial and occupational features, in order to determine whether 
this intervention would be effective in the short and medium 
terms to improve the symptoms of these patients.
Patients and Methods
After approval by the Ethics and Research Committee from 
FAMERP (2384/2010) and with the Free and Informed Consent 
Form (FICF) already signed, we conducted this single-center, 
randomized, single-blind, controlled trial. The trial was con-
ducted in two groups, with a duration of three months, com-
paring the weekly interdisciplinary program (WIP) to a con-
trol intervention consisting of educational guidelines for the 
prevention of pain, relaxation techniques, muscle stretching 
and body awareness. The sessions lasted 60 minutes each 
and happened once a week for 12 weeks for each of the study 
groups, being conducted by a physician, occupational thera-
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pist, physiotherapist, psychologist and social worker. After 
participating in this program, a revaluation was performed 
using the same instruments.
To perform WIP, 12 patients diagnosed with FMS (test 
group – TG) were recruited according to criteria of the Ameri-
can College of Rheumatology,1 of both genders, with enough 
cognitive level to understand the procedures and follow the 
directions given. Patients with psychiatric disease and no 
clinical follow-up in the Pain Clinic, Hospital de Base, were 
excluded. The control group (CG) consisted of patients who 
were in interconsultation in the Pain Clinic and without diag-
nosis of musculoskeletal and neurological disorders, or with 
disabling complaints in these systems, with a recommenda-
tion for walking (pelvic pain, migraine, inflammatory bowel 
pain post-herpetic neuralgia).
CG consisted of subjects matched for age and educational 
level in relation to TG (n = 15). The evaluation of the subjects 
in both groups was performed using the Fibromyalgia Impact 
Questionnaire (FIQ),19 involving 20 questions divided into 
10 items (functional capacity, feeling good, work absentee-
ism, interference of symptoms at work, pain, fatigue, morn-
ing stiffness, morning tiredness, anxiety and depression), in 
which nine of them have a higher score as the worst condi-
tion, with the exception of the item “feeling good”. Seven of 
the nine items (4th to 10th) are scored using a visual analogue 
scale, i.e., between 0 and 10.
Functional capacity is estimated by answering 10 ques-
tions, with answers from 0 to 3, which are added at the end 
of the questionnaire, ranging between 0 and 30. The “work ab-
senteeism” and “feeling good” questions are scored on week-
days, originally ranging from 0 to 5; the Visual Analogue Scale 
(VAS),20 which consists of measuring the intensity of pain in 
the patient and is an important tool to verify more reliably the 
evolution of the patient during treatment and even at every 
visit, consists of a limited strip of 10 cm in length, represent-
ing a continuum of the painful experience; this strip has in 
her ends anchor-words: “no pain” and “worst pain possible”. 
The participants are instructed to report the intensity of pain 
sensation to a point of this line, and the scores can range from 
zero to 10 and are obtained by measuring, in millimeters, the 
distance between the end anchored by the words “without 
pain” and the point marked by the participant; the Post-Sleep 
Protocol (PSP),21 which assesses the sleep quality and features 
30 items divided into three categories: pre-sleeping (at bed-
time), during sleep and post-sleeping (awakening) (30-390; 
higher scores are related to better quality of sleep). To assess 
the quality of life, the Generic Quality of Life SF-1222 question-
naire was used. It consists of 12 questions that address the 
physical component (functional capacity and limitation by 
physical aspects) and the mental component (pain, vitality, 
social functioning, limitations due to emotional problems and 
mental health), and their results are expressed by a score in 
a scale of zero to 100 by researched component (worst – best 
general health, cutoff score ≤ 50).
To assess depressive and anxiety symptoms, we used the 
Hospital Anxiety and Depression (HAD) scale,23 translated and 
validated in Brazil, which consists of a self-report instrument 
containing 14 multiple choice questions, composed of two in-
terleaved sub-scales: one for anxiety-state (7 questions) and 
another for depression-state (7 questions). HAD scores range 
from 0 to 21 points, and the subjects with scores < 7 are con-
sidered without significant clinical symptoms for anxiety 
and/or depression; scores ≥ 8 and ≤ 10, with mild symptoms; 
scores ≥ 11 and ≤ 14, with moderate symptoms; and scores ≥ 
15 and ≤ 21, with severe symptoms of anxiety and/or depres-
sion.
During the sessions, exercises to strengthen the muscle 
and to improve cardiovascular fitness were conducted, con-
sisting of stretching exercises of muscle groups of the shoul-
der and pelvic girdle, lower limb muscles, gluteus, abdominals 
and quadriceps, as well as body correction and awareness, 
and ergonomics. The sessions were initiated with relaxation 
techniques to combat muscle tension. Educational, psychoso-
cial and occupational programs were also developed to help 
understand and manage fibromyalgia, with the monitoring of 
vital signs at the beginning and end of each treatment session 
and the questioning on the use of drugs by patients. All the 
participants were instructed and taught to practice a series of 
daily exercises at home. It emphasized the need to maintain 
the home exercise program, and guidelines were given on the 
correct way to perform ADLs and AVPs.
Analyses were performed using ANOVA. This descriptive 
parametric statistical test was selected for inferential analy-
ses, because the dependent variables of this trial were quanti-
tative (interval scale). The significance level used for the tests 
was 0.05.
Results
The twenty-seven subjects enrolled in both groups adhered 
totally to the program, with no occurrence of sample loss. 
The mean age was 42.5 ± 9.8 years, ranging from 28-67 
years; most of the participants were female (64%). The mean 
duration of pain was 4.2 years, with an average of two years 
for the clinical diagnosis of FMS in TG. Table 1 lists the charac-
terization of the sample for the two groups (T and C).
During the experimental phase, all patients in the T group 
maintained their pharmacological routine. Significant differ-
ence was observed between the groups regarding the func-
tional capacity and work absenteeism, observed in the FIQ 
questionnaire. As for the other questionnaires used in this 
trial, data of mean and standard deviation (SD) can be ob-
tained from Table 2. 
It is important to notice, in Fig. 1, the frequency of de-
pressive and anxiety symptoms. It is noteworthy that 50% 
of patients with FMS in T group had depressive symptoms, 
and 33% had moderate to severe symptoms. 78% of these in-
dividuals had symptoms of anxiety, and in 43% of them the 
symptoms were severe.
Discussion 
The actions performed in this trial by the weekly interdis-
ciplinary program (WIP) demonstrated that the approach to 
individuals with FMS showed statistically significant clinical 
effects, as the increase of functional capacity and motivation, 
as well as greater control of symptoms such as sleep, anxiety 
and depression. 
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With regard to functional capacity, it was found that in 
group T the activities in WIP improved the energy that comes 
from the symptoms of chronic fatigue and stiffness, corrobo-
rating other trials.23,24
Other work on the impairment of muscle contractility in 
a group of fi bromyalgia patients is associated with a higher 
perception of effort and reduced maximal exercise capac-
ity. Due to this fact, the inclusion of physical activity in the 
treatment of these patients would improve their functional 
responses, with decreased fatigue and increased functional 
capacity.25 
Firestone et al.26 evaluated the impact of a program of group 
therapy for patients with fi bromyalgia. The sessions consist-
ed of behavioral modifi cations, stress reduction techniques, 
strategies to improve fl exibility and physical performance, in 
addition to sessions for familial help. The sessions were held 
weekly for a period of six months. The authors report promis-
ing results obtained in the short and long terms.
There was also a decrease in symptoms of depression and 
anxiety in WIP participants. 
Among the various factors affecting the QoL of fi bromyal-
gia patients, Aliciati et al.27 suggest that the presence of de-
pression predisposes patients to impaired social functioning, 
and Clark et al.23 reported that the inclusion of these patients 
in multidisciplinary groups favors the practice of daily living 
activities, mobility and quality of body movements and of 
physical fi tness, thereby improving their quality of life.
Table 1 – Data on sociodemographic variables for T 
(n = 12) and C groups (n = 15)
Variable Group n Mean ± 
SD
%
Age Test
Control
12
15
39,5±7,8
45,5±8,3
Gender Test
Control
12
15
8,3 ± 4,5 
years
Female 62
Female 55
Marital 
status
Test 12 Married 52 
Single 28 
Divorced 20
Control 15 Married 43 
Single 37 
Divorced 13 
 Widowed 7
Education Test 12 Fundamental 32 
Secondary 48
Superior 20
15 Fundamental 37 
Secondary 45
Superior 18
Employment 
situation
Test 12 Formal work 12 
Sick-leave aid 58
Retired 4
Informal work 26
Control 15 Formal work 20 
Sick-leave aid 48
Retired 6
Informal work 26
Table 2 – Change in mean values of FIQ, SF-12 and Post-Sleep Protocol (SIP) questionnaire domains throughout the 
follow-up period, expressed as mean ± standard deviation and variation
Instruments applied 1st review 
 Mean and SD 
 TG GC
2nd review 
 Mean and SD 
 TG GC
p value
FIQ
functional capacity 
Feeling good 
Work absences 
Ability to work 
Pain 
Fatigue 
Sleep 
Morning stiffness 
Anxiety 
Depression 
Total FIQ
12.4±7.7 9.3±5.9
2.0±2.6 4.8±2.7
0.0±0.0 0.0±0.1
6.6±2.8 5.1±3.1
7.7±1.8 5.7±3.0
7.5±2.3 5.7±2.0
6.6±3.0 4.1±3.1
7.5±2.5 5.3±7.9
7.6±2.5 4.3±3.3
7.0±2.5 3.4±3.1
 64.9±27.7 47.7±37.2
10.8±5.4 8.2±5.8
2.5±2.5 3.7±2.8
0.1±0.6 0.2±0.9
5.7±3.0 2.4±2.8
6.3±2.5 2.2±2.8
6.9±2.5 3.1±3.1
5.8±2.8 2.3±2.3
5.9±3.0 1.8±2.3
6.6±2.3 6.3±2.9
6.2±2.8 5.4±3.2
56.8±27.4 35.6±28.9
0.04*
0.06
0.20
0.03*
0.04*
0.04*
0.06
0.03*
0.03*
0.04*
0.03*
SF-12 
Physical component
Mental component
48.5 52.3
38.5 48.5
59.5 62.3
67.5 78.5
0.03*
0.001*
PSP
At bedtime 
Overnight
38.6±13.6 51.4±8.6
72.2±8.6 91.2±6.4
53.4±5.6 68.3±7.8
92.3±8.4 98.3±7.4
0.04*
0.03*
* statistically signifi cant difference, p < 0.05.
0%
10%
20%
30%
40%
50%
60%
70%
80%
GT GC
DEPRESSION
ANXIETY
Fig. 1 – Distribution of fi bromalgics according to the 
calculated mean of depression and anxiety symptoms
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Regarding the prescription of activities and exercises to 
patients with FMS, orientations, as well as pharmacologi-
cal prescriptions with dose, duration and specific intervals, 
were performed. The concern in relation to the intensity and 
execution of the proposed and previously trained activities 
in WIP began gradually, considering the preferences of pa-
tients, their comorbidities, medication use, and functional 
capacity. 
Corroborating this procedure, the trial by Miró et al.28 in-
volved different areas in action groups with expertise on fi-
bromyalgia patients, showing that they are promoters of pain 
relief, generating well-being and contributing significantly to 
the quality of the patients’ life.
Regarding the sleep, some trials29,30 relate a worst sleep-
ing period to a greater number of tender points in patients 
with fibromyalgia. Sleep disturbances were also associated 
with chronicity of pain complaints. It is known that individu-
als with chronic pain, such as those with FMS, have a persis-
tent health condition that changes their life. The goal of their 
treatment is to control FMS and not to seek its elimination; 
therefore, the sleep pattern assessment becomes a sensitive 
indicator that should be considered. In this trial, after the in-
tervention of WIP (with approaches focused on body biome-
chanics, kinesiology, ergonomics, psychosocial aspects and 
improvement of cardiorespiratory capacity), a better sleep 
pattern was noted in these individuals.
Follow-up studies with FMS patients are scarce, as well as 
those on the health care, that should have an interdisciplin-
ary planning, but they have been performed separately by 
each professional. 
The actions resultant of WIP revealed that the approach 
to patients with FMS should be multifactorial; this strategy 
enables the understanding of this syndrome as a summation 
of disorders that end up manifesting itself by the association 
of a variety of symptoms.
Conclusion
The treatment of fibromyalgia patients should follow multi-
factorial models; this will allow a systematic development of 
the necessary abilities to the transition from rehabilitation in 
the maintenance of an active and independent lifestyle.
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